Phase I, randomised, open-label study evaluating the pharmacokinetics, pharmacodynamics and tolerability of intranasal midazolam in patients with epilepsy on stable antiepileptic drug (AED) regimens
Latest Information Update: 17 Apr 2014
At a glance
- Drugs Midazolam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 14 Dec 2012 New trial record
- 03 Dec 2012 Results published in an Upsher-Smith media release.